Center for Anti-Infective Agents, Vienna, Austria
Ursula Theuretzbacher is an independent expert for antibacterial drug research, discovery/development strategies and policies based on clinical and public health needs. Her broad area of expertise includes public and philanthropic funding strategies for antibacterial drug R&D and initiatives to recover the global pipeline, evaluation and comparative assessment of antibacterial drugs, and optimization of antibacterial therapy concepts. She was member of the coordinating group of the WHO project Priority Pathogen List for R&D and leading scientist for the Clinical and Preclinical Pipeline analysis, and development of Target Product Profiles at WHO. Previously, she collaborated in several large EU funded projects focused on antibacterial drug R&D and reviving of old antibiotics. Additionally, she served as President of the International Society for Anti-Infective Pharmacology (ISAP) and as Executive Committee member of the International Society for Infectious Diseases (ISID). She holds a PhD in Microbiology from the University of Vienna and the University of Innsbruck in Austria and lectured at the University of Vienna for 10 years.